Visiongain Publishes Cranial Clamps Market Report 2020-2030

07 June 2020
Pharma

Visiongain has launched a new pharma report Cranial Clamps Market Report 2020-2030: Forecasts by Application (Imaging, Surgery), Patient (Adult, Pediatric), End User (Ambulatory Surgical Centers, Clinics, Hospitals), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).

The global cranial clamps market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz million by 2020. Visiongain anticipates that the global market will grow on account of the growing number of neurosurgeries, rising healthcare infrastructure, a growing number of hospitals, development of specialty neurosurgical centers among other growth contributing factors.

Cranial clamps are surgical tools used to secure the head during skull surgery. These instruments are used as holds to secure the head of the patient to increase access to the neurosurgery. Cranial clamps are seen in a variety of treatments, such as craniotomy for tumor removal; brain trauma; cerebrovascular diseases such as aneurysms; and neurodegenerative illnesses such as Parkinson's disease or epilepsy.

Also, a rise in the incidence of brain tumors and severe brain injury is projected to fuel demand development over the forecast period. As stated by the CDC, traumatic brain injury has been the leading cause of death over the last decade. As stated by the American Association of Neurosurgical Surgeons, more than 1.5 million instances of traumatic brain injury are identified per year. As a consequence, the need for neurosurgery is growing and the market development of cranial clamps is further anticipated to grow.

North America dominated the global cranial clamps market owing to the rising number of surgical procedures for tumor removal across the region. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing healthcare expenditure coupled with growing government initiatives to strengthen the healthcare sector across the region. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the cranial clamps market growth over the forecast period.

Currently, the global cranial clamps market is fragmented and key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global cranial clamps market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the cranial clamps market.

The comprehensive market report features companies such as ALLEN MEDICAL, B. BRAUN MELSUNGEN AG, Changzhou Huida, Depuy Synthes, ESCHEMANN HOLDINGS LTD, Evonos, Integra Lifesciences, Jeil Medical, KLS Martin, Medicon, Medtronic, Micromar and e.com, Neos Surgery, Osteomed, Pro Med Instruments, Stryker, and Zimmer Biomet among other prominent players. Also, the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes European Antibiotics Market Report 2021-2031

Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout the industry.

22 June 2021

Read

Visiongain Publishes Companion Diagnostics (CDx) Market Report 2021-2031

Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy.

17 June 2021

Read

Visiongain Publishes Cellular Immunotherapy Market Report 2021-2031

Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.

15 June 2021

Read

Visiongain Publishes Gene Therapy R&D Market Report 2021-2031

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

14 June 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever